Recombinant individual's interleukin 2 has proven to be a significant component in immune therapy for a range of cancers . This detailed review investigates its mechanism of action , covering its function in enhancing immune cells growth and killer cell response. We also analyze therapeutic uses , difficulties , and emerging pathways for optimizing